Invesco Discovery Fund Class R6 ODIIX

Morningstar Medalist Rating
  • NAV / 1-Day Return $158.41  /  +1.16 %
  • Fund Size $7.4B
  • Adjusted Expense Ratio 0.650%
  • Net Expense Ratio 0.650%
  • Fee Level: Distribution Low
  • Share Class Type Retirement, Large
  • Morningstar Category Small Growth
  • Equity Style Box (Funds) Small Growth
  • Minimum Initial Investment $1M
  • Investment Status Limited
  • TTM Yield 0.00%
  • Turnover Ratio 87%

Morningstar’s Analysis ODIIX

Will ODIIX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

An experienced team sporting an impressive record.

 Gregg Wolper

Gregg Wolper

Summary

Invesco Discovery’s stable, experienced management team has achieved excellent long-term results with an approach that combines a willingness to pay high prices for fast growers with tactics that mitigate the risks.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ODIIX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 20.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Ligand Pharmaceuticals Inc

2.43 180M
Healthcare

BrightSpring Health Services Inc

2.34 173M
Healthcare

JFrog Ltd Ordinary Shares

2.30 171M
Technology

Guardant Health Inc

2.09 155M
Healthcare

Repligen Corp

2.00 148M
Healthcare

Halozyme Therapeutics Inc

1.99 147M
Healthcare

Sanmina Corp

1.90 141M
Technology

Chord Energy Corp Ordinary Shares - New

1.89 140M
Energy

Enova International Inc

1.84 137M
Financial Services

WisdomTree Inc

1.65 123M
Financial Services

Sponsor Center